Product NDC: | 0406-9202 |
Proprietary Name: | FENTANYL CITRATE |
Non Proprietary Name: | FENTANYL CITRATE |
Active Ingredient(s): | 200 ug/1 & nbsp; FENTANYL CITRATE |
Administration Route(s): | TRANSMUCOSAL |
Dosage Form(s): | LOZENGE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0406-9202 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078907 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100115 |
Package NDC: | 0406-9202-30 |
Package Description: | 30 BLISTER PACK in 1 CARTON (0406-9202-30) > 1 LOZENGE in 1 BLISTER PACK |
NDC Code | 0406-9202-30 |
Proprietary Name | FENTANYL CITRATE |
Package Description | 30 BLISTER PACK in 1 CARTON (0406-9202-30) > 1 LOZENGE in 1 BLISTER PACK |
Product NDC | 0406-9202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FENTANYL CITRATE |
Dosage Form Name | LOZENGE |
Route Name | TRANSMUCOSAL |
Start Marketing Date | 20100115 |
Marketing Category Name | ANDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | FENTANYL CITRATE |
Strength Number | 200 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |